Breaks Categories: News

TuesdayOct 25, 2016 3:47 pm

Second Sight (EYES) Shares Soar on Implant and Activation of Wireless Visual Cortical Stimulator in First Human Subject

Shares of Second Sight Medical Products (NASDAQ: EYES) are moving higher on news that the implantable visual prosthetics company has successfully implanted and activated a wireless visual cortical stimulator in a human subject. The company said the achievement provides the initial human proof of concept for the ongoing development of the company’s Orion™ I Visual Cortical Prosthesis (Orion I). “Based on these results, stimulation of the visual cortex has the potential to restore useful vision to the blind, which is important for independence and improving quality of life,” Dr. Nader Pouratian, the UCLA neurosurgeon who performed the surgery, stated in…

Continue Reading

TuesdayOct 25, 2016 11:01 am

Towerstream Corporation (TWER) Shares Trend Higher on Plans to Double New Buildings

Towerstream (NASDAQ: TWER) this morning announced its plans to add 100 new buildings to its On-Net footprint in the fourth quarter, sending shares higher in early trade. “There is momentum in our business now,” Arthur Giftakis, chief operating officer, stated in the news release. “We accelerated our On-Net platform in Q1 of this year and already 48 percent of our buildings have multiple customers and several have more in this early stage of our expansion initiative.” The company also briefly discussed its pursuit of “select M&A transactions.” To view the full press release, visit: http://nnw.fm/rCpX5 About Towerstream Corporation Towerstream Corporation (NASDAQ:…

Continue Reading

TuesdayOct 25, 2016 11:00 am

Dipexium Pharmaceuticals, Inc. (DPRX) Shares Tumble on Disappointing Locilex® Phase 3 Studies

Shares of Dipexium Pharmaceuticals (NASDAQ: DPRX) plummeted more than 80% after the company reported that OneStep phase 3 clinical trials of its lead candidate Locilex® failed to meet primary or secondary endpoints in the treatment of mild infections of diabetic foot ulcers. "Although we are disappointed with these results, we are continuing to evaluate the data and will consider potential regulatory pathways forward in other possible clinical indications based on an evaluation of all data emerging from the phase 3 studies,” David P. Luci, president and CEO of Dipexium, stated in the news release. To view the full press release,…

Continue Reading

MondayOct 24, 2016 5:08 pm

Xplore Technologies Corp. (XPLR) Posts Preliminary Q2 Results, Expectations for Profitable Second Half

Xplore Technologies (NASDAQ: XPLR) this afternoon posted preliminary second-quarter results, updated its revenue outlook for fiscal 2017, and forecast second half profitability “to drive approximately breakeven net income for the full year.” “We anticipate revenue of approximately $20.0 million in our fiscal second quarter … As a result, we entered the December quarter with record backlog of more than $11 million,” Mark Holleran, Xplore’s president and chief operating officer, stated in the news release. The company guides revenue to be at the lower end of its initial $85 million to $95 million outlook. Full results are expected November 10. For…

Continue Reading

MondayOct 24, 2016 4:59 pm

OpGen Inc.’s (OPGN) Q3 Results Drag Shares Lower After-Hours

OpGen (NASDAQ: OPGN) this afternoon posted its third quarter and nine-month financial results, sending shares 20% lower after hours. Total revenue for the third quarter of 2016 was $0.8 million, down 23% year-over-year. Net loss attributable to common stockholders for the third quarter of 2016 was $4.8 million, or $0.23 per share, compared with a net loss attributable to common stockholders for the third quarter of 2015 of $4.7 million, or $0.38 per share. To view the full press release, visit:  http://nnw.fm/XIjl2 About OpGen OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for…

Continue Reading

MondayOct 24, 2016 10:36 am

PositiveID Corporation (PSID) Shares Surge on Average Monthly Sales Hike

PositiveID (OTCQB: PSID) this morning reported increased monthly sales of its FDA-cleared non-contact thermometer, driving shares 47% higher in early trade. The life sciences company said that Q2 and Q3 sales of its Caregiver® thermometer increased roughly 60% compared to Q1 among accounts served by Vizient, Inc., the largest member-driven health care performance improvement company in the country, during its National Group Buy Program. To view the full press release, visit:  http://nnw.fm/wVKD8 About PositiveID Corporation PositiveID Corporation is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the…

Continue Reading

FridayOct 21, 2016 12:52 pm

Inventergy Global, Inc. (INVT) Regains Listing Requirement, Pushing Shares Higher

Inventergy Global (NASDAQ: INVT) is trading 5% higher Friday mid-day after the intellectual property company announced its compliance for listing on Nasdaq. After completing its recent $6 million offering, Inventergy's stockholders' equity exceeded Nasdaq's minimum requirement of $2.5 million. The company was also required to submit, by October 15, 2016, certain financial information including a plan of compliance through the rest of 2016 and 2017. Nasdaq accepted the plan submitted by Inventergy and has since confirmed the company's compliance. To view the article, visit: http://nnw.fm/hV6mD About Inventergy Global, Inc. Inventergy Global, Inc. is a Silicon Valley-based intellectual property company dedicated…

Continue Reading

FridayOct 21, 2016 12:50 pm

MassRoots, Inc. (MSRT) Raises $5M, Marking Company Milestone

MassRoots (OTCQB: MSRT) shares climbed 7% Friday morning following the company’s announcement that it has completed its $5.0 million equity offering under its Registration Statement, declared effective by the SEC in August. The company said the offering provides its largest cash on hand in its corporate history and that “these funds are sufficient for the Company to reach cash-flow positive and to scale our commercialization efforts to a much wider audience.” To view the full press release, visit: http://nnw.fm/m9U7T About MassRoots MassRoots is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over…

Continue Reading

FridayOct 21, 2016 12:47 pm

FlitWays (CATQ) to Provide Rides for Xerox (XRX): Go City Apps, Shares Climb

Shares of FlitWays (OTC: CATQ) are slightly higher in Friday’s mid-day trade after the ground travel technology company this morning announced its distribution agreement with Xerox (NYSE: XRX) in which FlitWays will provide ride supply for the Xerox: Go City apps, currently available in Los Angeles (Xerox: Go LA) and Denver (Xerox: Go Denver). FlitWays is a wholly owned subsidiary of Cataca Resources, Inc. "With many more Xerox Go apps planned for other cities around the country and internationally, we expect our ground travel network will book an increasingly larger number of trips as this rollout continues and awareness of our…

Continue Reading

ThursdayOct 20, 2016 4:37 pm

Pain Therapeutics, Inc. (PTIE) Trims Q3 Loss

Pain Therapeutics (NASDAQ: PTIE) today reported results for the third quarter of 2016, posting a net loss of $3.5 million, or $0.08 per share, compared to a net loss of $3.7 million, or $0.08 per share, in the comparable quarter of the year prior. At September 30, 2016, Pain Therapeutics reports cash and investments of $21.8 million, compared to $24.6 million at June 30, 2016.  The company is debt-free. To view the full press release, visit:  http://nnw.fm/Vi4Fo About Pain Therapeutics, Inc. We develop proprietary drugs that offer significant improvements to patients and physicians. Our expertise consists of developing new drugs…

Continue Reading